Morgan Stanley »

Indaptus Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Indaptus Therapeutics (INDP) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Indaptus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Indaptus Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indaptus Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.9k 2.7k 1.82

More positions owned by Morgan Stanley

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)

View all positions for Morgan Stanley

Top funds holding Indaptus Therapeutics

Citadel Advisors
Geode Capital Management
Tower Research Capital
Morgan Stanley
SBI Securities

View all funds holding Indaptus Therapeutics